Edward Eunkee Whang, MD

Adjunct Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Whang, MD is a practicing Surgeon in Boston, MA. Dr. Whang graduated from University of Chicago Pritzker School of Medicine in 1991 and has been in practice for 28 years. He completed a residency at UCLA Medical Center. Dr. Whang is board certified in Surgery. Dr. Whang also practices at Boston Vamc in Jamaica Plain, MA.

Publications

  • Published 5/15/2025

    Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Adenocarcinoma Cell Gemcitabine Chemoresistance. Clin Cancer Res. 2025 May 15; 31(10):2065. PMID: 40370046.

    Read at: PubMed

  • Published 4/30/2025

    Liau SS, Jazag A, Ito K, Whang EE. Retraction Note: Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells. Br J Cancer. 2025 Apr 30. PMID: 40307441.

    Read at: PubMed

  • Published 8/31/2024

    Smith SM, Chugh PV, Song C, Kim K, Whang E, Kristo G. Perspectives of Surgical Research Residents on Improving Their Reentry Into Clinical Training. J Surg Educ. 2024 Nov; 81(11):1491-1497. PMID: 39217679.

    Read at: PubMed

  • Published 6/20/2024

    Chugh PV, Smith SM, Whang E, Kristo G. Standing with our Veterans: Improving access to Veterans Affairs healthcare for their families. Am J Surg. 2024 Oct; 236:115807. PMID: 38925994.

    Read at: PubMed

  • Published 8/1/2023

    Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. Oncogene. 2023 Aug; 42(34):2589. PMID: 37468680.

    Read at: PubMed

Education

  • Pritzker School of Medicine, MD
  • Massachusetts Institute of Technology, BS